Literature DB >> 2741884

Risk factors for first operation in Crohn's disease.

G Basilisco1, M Campanini, B Cesana, T Ranzi, P Bianchi.   

Abstract

We studied 267 consecutive Italian patients (146 male, 121 female) with Crohn's disease. Median time from the first symptom to diagnosis at our center was 21 months (range 1-372), whereas median follow-up from the first visit was 38 months (range 1-180). The disease affected the small bowel in 93 (35%) cases, the ileum and colon in 76 (28%), and the colon in 98 (37%). Forty-nine percent of the patients underwent major abdominal surgery for the disease at least once. The cumulative probability of abdominal surgery was 36% and 55%, 60 and 120 months after the onset of symptoms, respectively. Univariate analysis indicated that patients with colon involvement (p less than 0.0001), those with a longer interval between first symptom and diagnosis (p less than 0.0001), and those at an older age at diagnosis (p less than 0.0003) had a significantly greater probability of escaping abdominal surgery. The interval between first symptom and diagnosis, the site of disease, and the age at diagnosis were confirmed as risk factors for surgery, in decreasing order of importance, by multivariate analysis with Cox's proportional hazard model. A prognostic index for first operation based on these variables is proposed.

Entities:  

Mesh:

Year:  1989        PMID: 2741884

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  8 in total

1.  Risk factors for surgery and postoperative recurrence in Crohn's disease.

Authors:  O Bernell; A Lapidus; G Hellers
Journal:  Ann Surg       Date:  2000-01       Impact factor: 12.969

2.  Cumulative Inflammation Could Be a Risk Factor for Intestinal Failure in Crohn's Disease.

Authors:  Yoshifumi Watanabe; Norikatsu Miyoshi; Shiki Fujino; Hidekazu Takahashi; Naotsugu Haraguchi; Taishi Hata; Chu Matsuda; Hirofumi Yamamoto; Yuichiro Doki; Masaki Mori; Tsunekazu Mizushima
Journal:  Dig Dis Sci       Date:  2019-02-26       Impact factor: 3.199

Review 3.  Clinical literature review of 1858 Crohn's disease cases requiring surgery in China.

Authors:  Qing-Hai Peng; Yu-Fang Wang; Man-Qing He; Cui Zhang; Qin Tang
Journal:  World J Gastroenterol       Date:  2015-04-21       Impact factor: 5.742

4.  Crohn's disease patients carrying Nod2/CARD15 gene variants have an increased and early need for first surgery due to stricturing disease and higher rate of surgical recurrence.

Authors:  Manuel Alvarez-Lobos; Juan I Arostegui; Miquel Sans; Dolors Tassies; Susana Plaza; Salvadora Delgado; Antonio M Lacy; Josep M Pique; Jordi Yagüe; Julián Panés
Journal:  Ann Surg       Date:  2005-11       Impact factor: 12.969

5.  Risk Factors for Surgery in Pediatric Patients with Crohn's Disease.

Authors:  Rayna Rumenova Shentova-Eneva; Denitza Kofinova; Petyo Hadzhiyski; Ekaterina Ivanova-Todorova; Penka Yaneva; Elena Lazarova; Mila Baycheva
Journal:  Med Princ Pract       Date:  2022-01-27       Impact factor: 2.132

6.  Anti-Saccharomyces cerevisiae antibody (ASCA) positivity is associated with increased risk for early surgery in Crohn's disease.

Authors:  D G Forcione; M J Rosen; J B Kisiel; B E Sands
Journal:  Gut       Date:  2004-08       Impact factor: 23.059

7.  Identifying patients with a high risk of relapse in quiescent Crohn's disease. The GETAID Group. The Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives.

Authors:  T Sahmoud; G Hoctin-Boes; R Modigliani; A Bitoun; J F Colombel; J C Soule; C Florent; J P Gendre; E Lerebours; R Sylvester
Journal:  Gut       Date:  1995-12       Impact factor: 23.059

8.  Long-term incidence and characteristics of intestinal failure in Crohn's disease: a multicenter study.

Authors:  Kazuhiro Watanabe; Iwao Sasaki; Kouhei Fukushima; Kitaro Futami; Hiroki Ikeuchi; Akira Sugita; Riichiro Nezu; Tsunekazu Mizushima; Shingo Kameoka; Masato Kusunoki; Kazuhiko Yoshioka; Yuji Funayama; Toshiaki Watanabe; Hisao Fujii; Mamoru Watanabe
Journal:  J Gastroenterol       Date:  2013-04-07       Impact factor: 7.527

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.